Application
TINAGL1 Antibody (C-term) western blot analysis in mouse heart tissue lysates (15ug/lane).This demonstrates the TINAGL1 antibody detected TINAGL1 protein (arrow).| Product Name | TINAGL1 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | GIS5, LCN7, OLRG2, TINAGL |
|---|---|
| Alternative Names | TINAGL1 GIS5 LCN7 OLRG2 TINAGL Tubulointerstitial nephritis antigen-like Glucocorticoid-inducible protein 5 Oxidized LDL-responsive gene 2 protein Tubulointerstitial nephritis antigen-related protein |
| Molecular Weight(MW) | 52387 Da |
| Function | May be implicated in the adrenocortical zonation and in mechanisms for repressing the CYP11B1 gene expression in adrenocortical cells. This is a non catalytic peptidase C1 family protein (By similarity) |
| Tissue Specificity | Highly expressed in aorta, heart, placenta, kidney and a colorectal adenocarcinoma cell line. Moderately expressed in skeletal muscle, pancreas, lung, lymph nodes, adrenal gland, bone marrow and thyroid. Weakly expressed in colon, small intestine, ovary, spleen, testis and prostate. Predominantly found in vascular smooth muscle cells, but also in cardiac and skeletal muscle cells as well as kidney |
| Cellular Localization | Secreted. |
| Entrez Gene | 64129 |
|---|---|
| Nucleotide Accession | NP_071447.1 |
Application
TINAGL1 Antibody (C-term) western blot analysis in mouse heart tissue lysates (15ug/lane).This demonstrates the TINAGL1 antibody detected TINAGL1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
